The acquisition will help accelerate Aspirion’s investment in intelligent automation to advance operational effectiveness, recovery yield and pace of collections for its clients, according to a Sept. 12 Aspirion news release.
Infinia ML will operate as Aspirion’s research and development engine, “focusing on leap-ahead AI capabilities to drive improved financial performance for healthcare providers,” according to the release.
